MedPath

To evaluate the efficacy of Madhuyashti Granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children.

Phase 1
Conditions
Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type
Registration Number
CTRI/2023/04/052151
Lead Sponsor
RGGPG Ayurvedic College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Individual between age group of 6 to 15 years of

both genders having fulfilled DSM V criteria.

2. Children with IQ > 80.

3. Parents of patient willing to participate in the

trial.

Exclusion Criteria

1. Individuals below 6 years & above 15 years of

age.

2. Mental disorders like conduct disorder,

anxiety, depressive disorders, obsessive

disorders & compulsive disorder.

3. Children with schizophrenia.

4. Children having medical illness like hearing

loss, hypothyroidism, genetic disorder &

seizures.

5. Children having congenital deformity or

Muscular dystrophy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath